# clm_E4A47C6EE8A9

subject: Regeneron Pharmaceuticals (/record/regeneron-pharmaceuticals.md)  
predicate: total_equity  
value: 371,216,000 United States dollar  
valid_from: 2010-06-30  
valid_to: 2010-09-30  
published: 2010-07-28  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_64A26E8ED78A  
last_updated: 2026-11-08  
cite: AsOf. "Regeneron Pharmaceuticals total equity: 371,216,000 United States dollar", as of 2010-06-30 (until 2010-09-30). Claim clm_E4A47C6EE8A9, https://asof.is/claim/clm_E4A47C6EE8A9, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q2 FY2010, filed 2010-07-28  

## Sources

- https://www.sec.gov/Archives/edgar/data/872589/000120677410001689/0001206774-10-001689-index.htm (primary, SEC EDGAR 10-Q Q2 FY2010, published 2010-07-28)

## Supersedes

- [Regeneron Pharmaceuticals](/record/regeneron-pharmaceuticals.md) | total_equity | 386,271,000 United States dollar | valid 2010-03-31 to 2010-06-30 | conf 0.95 | superseded | superseded_by [clm_E4A47C6EE8A9](/claim/clm_E4A47C6EE8A9.md) | [clm_CBE9497E634B](/claim/clm_CBE9497E634B.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.